Ensign Peak Advisors, Inc
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1454984
SALT LAKE CITY, UT
Position in PTGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$464,087
-$8,737 QoQ
Shares Held
3,786
-15.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#217
of 341 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. PTGX ranks #87 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in PTGX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $464,087 | 3,786 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $472,824 | 4,486 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $391,807 | 4,486 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $729,799 | 10,986 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,278,726 | 23,136 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,307,460 | 27,036 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,043,589 | 27,036 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,216,620 | 27,036 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $936,797 | 27,036 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $782,151 | 27,036 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $651,212 | 28,400 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $473,712 | 28,400 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $450,206 | 16,300 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $103,436 | 12,270 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $84,478 | 10,680 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $252,902 | 10,680 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $365,256 | 10,680 | Shares | Sole | 2022-02-11 | |
| 2021-06-30 | $1,491,362 | 33,230 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $860,657 | 33,230 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $669,916 | 33,230 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $732,186 | 37,452 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||